Butyryl Chloride Market

USD 518.0 million by 2036 at a 4.3% CAGR.

• The Butyryl Chloride Market reached USD 326.0 million in 2025.
• Demand is projected to rise from USD 340.0 million in 2026 to USD 518.0 million by 2036.
• The market is projected to expand at a 4.3% CAGR from 2026 to 2036.

What are the defining numbers behind Butyryl Chloride Market growth?

An absolute opportunity of USD 178.0 million is expected between 2026 and 2036.

• Demand Drivers in the Market
  • Pharmaceutical and fine-chemical synthesis is a central demand mechanism. Thermo Scientific Chemicals identifies butyryl chloride as an acylation reagent and synthesis intermediate, while the U.S. Food and Drug Administration recorded 46 novel drug approvals in 2025 alongside continued generic approvals. More development and commercial synthesis campaigns increase demand for qualified acid chlorides and other pharma fine chemicals.
  • Crop-protection chemistry adds a second recurring outlet. Brazil's Ministry of Agriculture reported 912 pesticide and bioinput registrations in 2025, including 323 technical products intended for industrial use. Registration activity sustains synthesis work for herbicide and pesticide intermediates, connecting butyryl chloride demand with the agrochemical market and upstream intermediate supply.
  • Fine-chemical producers use butyryl chloride where fast, selective acylation helps introduce butyryl functionality into intermediates. Merck and Tokyo Chemical Industry both supply specification-controlled grades, supporting research, pilot and commercial routes across pharmaceuticals market, specialty chemicals and custom synthesis.
  • Agrochemical producers increasingly manage larger portfolios of technical products, generics and reformulated actives. That creates repeated procurement of acid chlorides and related building blocks used before final formulation, linking the market with broader crop protection chemicals manufacturing.
  • High-purity and specialty grades create smaller but higher-value demand. Suppliers offer 98% to at least 99% butyryl chloride with certificates and analytical documentation, enabling buyers to match impurity profiles to sensitive pharmaceutical, research and advanced synthesis steps.
  • Electronic-grade and high-purity chemical requirements create an additional qualification pathway. Although this is a smaller outlet than pharmaceuticals or agrochemicals, tighter impurity limits and controlled packaging can raise value per unit where customers use acid chlorides within specialty synthesis serving semiconductor chemicals.
• Key Segments Analyzed
  • Industrial Grade Butyryl Chloride accounts for 38.4% of Product in 2026. Its broad use in bulk acylation and intermediate synthesis reflects the need for dependable assay and moisture control without the cost of higher-purity grades.
  • Pharmaceuticals represents 42.7% of Application in 2026. Butyryl chloride is used as an acylating reagent in pharmaceutical and fine-chemical synthesis, where reaction consistency and controlled specifications are important.
  • Pharmaceutical Companies account for 36.9% of End Use in 2026. Repeated API and advanced-intermediate production creates recurring demand for qualified acid chlorides from approved suppliers.
  • Liquid holds 61.3% of Form in 2026. Its physical form allows controlled transfer and metering into closed reaction systems, making it practical for both laboratory and industrial synthesis.
  • Industrial Grade holds 44.8% of Purity Grade in 2026. Many chemical and agrochemical processes can operate with standard commercial specifications, avoiding the added purification required for more sensitive applications.
  • Direct Sales accounts for 59.7% of Distribution Channel in 2026. Bulk users often work directly with suppliers to manage hazardous-material transport, packaging requirements and batch specifications for this corrosive and moisture-sensitive chemical.
• Analyst Opinion at Fact.MR
  • “Butyryl chloride demand is shaped less by one finished product than by the number of synthesis campaigns that require controlled acylation. Suppliers that can maintain assay, moisture control, safe packaging and batch documentation across industrial and high-purity grades are positioned to serve pharmaceutical, agrochemical and specialty-chemical buyers with very different qualification thresholds.”
  • Shambhu Nath Jha, Principal Consultant, Fact.MR
• Strategic Implications
  • Producers need to match grade strategy with customer handling requirements. Industrial users typically buy larger volumes and focus on supply consistency, while pharmaceutical and research buyers place greater weight on impurity control, certificates and traceability. Suppliers that can separate purification and packaging workflows can serve both groups from the same production base.
  • Direct supplier relationships remain important for larger accounts because butyryl chloride requires careful transport and storage. Reliable specifications, suitable containers and responsive technical documentation can reduce procurement risk for buyers handling a flammable and moisture-sensitive reagent.
  • Commercial focus should follow areas with established pharmaceutical and chemical synthesis activity. Germany and the USA have substantial downstream manufacturing bases, Brazil adds demand from agrochemical production, while the UK and Japan support higher-specification demand through life-sciences and specialty-chemical activity.

The Butyryl Chloride Market is segmented by Product, Application, End Use, Form, Purity Grade and Distribution Channel.

Why does Industrial Grade Butyryl Chloride lead Product?

Industrial Grade Butyryl Chloride holds 38.4% of Product in 2026.

Bulk chemical and intermediate grades are suited to high-throughput acylation where customers need consistent reactivity, water exclusion and manageable cost rather than analytical-purity premiums. These conditions are common in chemical intermediates, agrochemical precursors and multi-step fine-chemical synthesis.

Higher-purity grades remain important for pharmaceutical and sensitive specialty routes, but they add purification, analytical and documentation costs. Industrial grades therefore retain the broadest addressable volume across processes that can qualify a standard specification.

Why do Pharmaceuticals lead Application?

Pharmaceuticals accounts for 42.7% of Application in 2026.

Thermo Scientific Chemicals describes butyryl chloride as an acylation reagent and synthesis intermediate. In pharmaceutical chemistry, acid chlorides provide a direct route to amides, esters and other acylated intermediates, making them useful where reaction efficiency and reproducibility support multi-step API or advanced-intermediate production.

The U.S. FDA approved 46 novel drugs in 2025 and continued to process first generic approvals, reinforcing a development environment with ongoing route optimization, scale-up and sourcing work. Not every drug requires butyryl chloride, but the volume of small-molecule synthesis programs sustains demand for qualified acylating reagents and fine-chemical building blocks.

Why do Pharmaceutical Companies lead End Use?

Pharmaceutical Companies account for 36.9% of End Use in 2026.

Pharmaceutical buyers often qualify reagents against route-specific impurity and documentation requirements before routine production. Once a butyryl chloride grade is accepted, repeat batch manufacturing and change-control procedures can favor stable supplier relationships, especially for intermediates used in regulated products.

Chemical manufacturers and specialty producers also purchase substantial volumes, but their applications are spread across agrochemicals, polymers, dyes and custom synthesis. Pharmaceutical companies concentrate demand in programs where reagent consistency and traceability can carry a higher commercial value.

Why does Liquid lead Form?

Liquid holds 61.3% of Form in 2026.

Merck, Tokyo Chemical Industry and Thermo Scientific Chemicals all commercialize butyryl chloride as a liquid. TCI identifies it as moisture sensitive and recommends storage under inert gas, while Thermo Scientific lists a boiling point near 102°C and a flash point near 18°C. These properties favor closed transfer, metering and controlled storage rather than open handling.

Intermediate solid derivatives can simplify particular downstream workflows, but they are not the primary physical form of butyryl chloride itself. Liquid supply therefore remains the practical standard for direct reaction charging from laboratory through industrial scale.

Why does Industrial Grade lead Purity Grade?

Industrial Grade holds 44.8% of Purity Grade in 2026.

Many large-volume chemical and agrochemical processes can qualify industrial material if assay, acidity, moisture and key impurities remain within process limits. This reduces the purification burden and supports better economics for intermediate production where the reagent is consumed early in a multi-step route.

Pharmaceutical and high-purity grades serve more sensitive steps and can command tighter documentation requirements. The broader number of processes able to use standard industrial specifications supports the leading share of Industrial Grade across the total market.

Why do Direct Sales lead Distribution Channel?

Direct Sales accounts for 59.7% of Distribution Channel in 2026.

Butyryl chloride carries hazardous-transport and handling requirements. Thermo Scientific classifies it as a flammable liquid that can cause severe burns and is toxic if inhaled, while commercial suppliers emphasize moisture-sensitive storage. Large users therefore benefit from direct coordination on container size, shipment timing, documentation and batch specifications.

Distributors and online B2B platforms remain useful for research and smaller-volume buyers, particularly where rapid availability matters. Direct sales dominate larger industrial programs because supplier qualification and hazardous-material logistics are more tightly integrated with plant purchasing and inventory control.

Demand is being accelerated by pharmaceutical and agrochemical intermediate synthesis, custom fine-chemical production, repeat acylation chemistry and tighter demand for documented high-purity grades. Growth is restrained by hazardous-material handling costs, moisture sensitivity, corrosivity, shipment restrictions and the need to qualify substitutes or alternative synthetic routes before changing reagent systems.

Drivers Impact Analysis

Opportunity Impact Analysis

Restraints Impact Analysis

• Germany has an established base of chemical and pharmaceutical manufacturing that supports demand for industrial and higher-purity butyryl chloride. Buyers in these sectors also place strong emphasis on handling standards and supplier documentation.
• Brazil’s demand is supported by agrochemical production and pharmaceutical manufacturing. Technical-product activity creates recurring requirements for acid-chloride intermediates used before final formulation.
• In the USA, pharmaceutical development and specialty-chemical production create demand across laboratory work, scale-up and commercial synthesis. Generic drug activity adds another source of repeat reagent procurement.
• The UK benefits from continued pharmaceutical production and life-sciences manufacturing activity. Demand is linked to domestic synthesis, process development and contract manufacturing.
• Japan combines pharmaceutical manufacturing with a well-developed specialty-reagent supply base. This supports demand for butyryl chloride in research, API intermediate production and specification-sensitive synthesis.

Country CAGR (2026-2036)

What is driving Germany's growth through 2036?

Germany is forecast to expand at a 5.0% CAGR from 2026 to 2036.

Destatis continues to track sizable domestic production in both chemical products and pharmaceuticals. That industrial combination is relevant to butyryl chloride because the reagent serves both broad chemical-intermediate synthesis and higher-specification pharmaceutical routes, allowing suppliers to address multiple customer types from the same regional logistics base.

German buyers also operate within mature chemical safety and quality systems. For a flammable, corrosive and moisture-sensitive acyl chloride, reliable packaging, transport classification, batch documentation and controlled storage can be as important as nominal assay, supporting direct supplier relationships and qualified grades.

What is driving Brazil's growth through 2036?

Brazil is forecast to expand at a 4.5% CAGR from 2026 to 2036.

Brazil's Ministry of Agriculture reported 912 pesticide and bioinput registrations during 2025, including 323 technical products intended exclusively for industrial use. This active technical-product pipeline supports demand for chemical intermediates and building blocks used upstream of formulated herbicides and pesticides.

IBGE also reported that farmochemical and pharmaceutical production increased 9.8% in November 2025 after two months of decline. The combination of crop-protection chemistry and pharmaceutical manufacturing creates two distinct consumption routes for butyryl chloride, reducing dependence on a single downstream industry.

What is driving USA's growth through 2036?

The USA is forecast to expand at a 4.1% CAGR from 2026 to 2036.

The U.S. FDA approved 46 novel drugs in 2025 and recorded 91 first generic approvals during the year. These approvals represent a continuing base of route development, process validation, generic scale-up and commercial manufacturing that consumes a wide range of acylating reagents and pharmaceutical intermediates.

Supplier infrastructure is also broad. Thermo Scientific Chemicals and Merck/Sigma-Aldrich list butyryl chloride in multiple pack sizes and high assay specifications, supporting research laboratories, custom synthesis teams and industrial buyers that require quick access to documented reagent grades.

What is driving UK's growth through 2036?

The UK is forecast to expand at a 3.7% CAGR from 2026 to 2036.

The UK Life Sciences Sector Plan, updated in 2026, targets stronger R&D, investment and advanced manufacturing. That policy direction is supportive for reagent and intermediate suppliers because domestic process development, pilot manufacture and contract production all require qualified fine chemicals during route development and scale-up.

The Office for National Statistics continues to track basic pharmaceutical and chemical production as distinct manufacturing subsectors. Even with monthly volatility, the presence of these sectors supports recurring demand for acid chlorides used in pharmaceutical and specialty-chemical synthesis.

What is driving Japan's growth through 2036?

Japan is forecast to expand at a 3.2% CAGR from 2026 to 2036.

Japan's Ministry of Health, Labour and Welfare annual pharmaceutical production statistics show a substantial domestic manufacturing base, while monthly e-Stat reporting tracks pharmaceutical production and shipments in detail. This supports ongoing reagent demand for API, intermediate and fine-chemical synthesis.

Japan also has strong local reagent infrastructure. Tokyo Chemical Industry supplies butyryl chloride at more than 98% purity with specification, safety and certificate documentation, which supports research, pilot and specialty synthesis users that place a premium on local availability and controlled quality.

Key players in the Butyryl Chloride Market include Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific, Otto Chemie Pvt. Ltd., Shandong Xinhua Pharmaceutical Company, Haihang Industry Co., Ltd. and Parchem Fine & Specialty Chemicals.

Competition centers on assay and impurity control, moisture management, hazardous-material packaging, pack-size range, batch certificates, synthesis-grade documentation, bulk availability and delivery reliability. Merck/Sigma-Aldrich, Tokyo Chemical Industry and Thermo Scientific Chemicals publicly list butyryl chloride in controlled specifications, illustrating how catalog access and documentation support both research and production buyers.

The key providers are Merck KGaA, Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific, Otto Chemie Pvt. Ltd., Shandong Xinhua Pharmaceutical Company, Haihang Industry Co., Ltd. and Parchem Fine & Specialty Chemicals.

• Merck KGaA
• Tokyo Chemical Industry Co., Ltd.
• Thermo Fisher Scientific
• Otto Chemie Pvt. Ltd.
• Shandong Xinhua Pharmaceutical Company
• Haihang Industry Co., Ltd.
• Parchem Fine & Specialty Chemicals

• Merck KGaA. (2026). Butyryl Chloride, 98% and >=99%. Sigma-Aldrich.
• Tokyo Chemical Industry Co., Ltd. (2026). Butyryl Chloride, Product B0770. Tokyo Chemical Industry.
• Thermo Fisher Scientific. (2026). Butyryl Chloride, 98% and 99% Product Information. Thermo Scientific Chemicals.
• U.S. Food and Drug Administration. (2026). Novel Drug Approvals for 2025. U.S. Department of Health and Human Services.
• U.S. Food and Drug Administration. (2026). 2025 First Generic Drug Approvals. U.S. Department of Health and Human Services.
• Federal Statistical Office of Germany. (2026). Production Index for Chemical and Pharmaceutical Manufacturing. Destatis.
• Ministry of Agriculture and Livestock. (2026). Annual Balance of Pesticide and Bioinput Registrations in 2025. Government of Brazil.
• Brazilian Institute of Geography and Statistics. (2026). Industrial Production, November 2025. IBGE.
• Department for Business and Trade et al. (2026). Life Sciences Sector Plan and One Year On Update. UK Government.
• Office for National Statistics. (2026). Index of Production, December 2025. UK Statistics Authority.
• Ministry of Health, Labour and Welfare. (2025). Annual Report of Statistics on Pharmaceutical and Medical Device Production, 2024. Government of Japan.
• Government of Japan. (2026). Monthly Statistics on Pharmaceutical and Medical Device Production. e-Stat.

• What is the Butyryl Chloride Market worth in 2026 and 2036?
• What CAGR is expected from 2026 to 2036?
• Which Product, Application, End Use, Form, Purity Grade and Distribution Channel lead in 2026?
• How do pharmaceutical and agrochemical synthesis affect butyryl chloride demand?
• Why are liquid supply and direct sales important for this reagent?
• Which countries are expanding demand through 2036?
• Which companies participate in the competitive landscape?
• What commercial revenue is included in the market boundary?

The market covers commercial butyryl chloride sold as an identifiable acyl-chloride reagent or intermediate across industrial, high-purity and specialty product grades. Revenue includes liquid butyryl chloride and specified derivative forms used in pharmaceutical, agrochemical, polymer, chemical, dye and pigment synthesis, supplied through direct or indirect channels.

What is included in the scope?

• Industrial Grade Butyryl Chloride, High Purity Butyryl Chloride and Specialty Derivatives, including the specified bulk, intermediate, pharmaceutical, electronic, butyryl-intermediate and custom-synthesis subgrades.
• Pharmaceutical, agrochemical, polymer and chemical, dye and pigment applications, including API synthesis, fine-chemical synthesis, herbicide and pesticide intermediates, polymer modification, industrial synthesis and color-chemical routes.
• Pharmaceutical companies, chemical manufacturers, agrochemical companies, specialty chemical producers and research and development laboratories.
• Liquid forms and specified intermediate solid derivatives, including bulk, stabilized, purified and reaction-stabilized forms.
• Industrial, technical, pharmaceutical and high-purity grades sold through direct sales, distributors and online B2B platforms.

What is excluded from the scope?

• Finished active pharmaceutical ingredients and formulated medicines where butyryl chloride is not sold as a separately identifiable reagent or intermediate.
• Finished pesticides, herbicides and other crop-protection formulations sold without separately identifiable butyryl chloride revenue.
• Finished polymers, coatings, dyes and pigments that consume butyryl-derived intermediates but do not include a commercial butyryl chloride transaction.
• Other acid chlorides, anhydrides and acylating agents whose primary chemistry is not butyryl chloride.
• Captive internal transfers that do not create a commercial sale.

How Was the Analysis Built?

The analysis draws on more than 120 sources, over 35 company portfolios and more than 20 industry interviews across at least 25 countries.

• Primary Research: Interviews with fine-chemical manufacturers, pharmaceutical and agrochemical procurement teams, custom synthesis companies, chemical distributors, logistics specialists and laboratory users examine grade selection, assay, moisture limits, packaging, shipment mode, supplier qualification and purchase volume.
• Desk Research: The review covers butyryl chloride technical specifications, hazard classifications, pharmaceutical approvals, pesticide registrations, chemical and pharmaceutical production, life-sciences manufacturing policy and current supplier portfolios. External sources used in the article are recorded in the bibliography.
• Market Sizing and Forecasting: Estimates combine pharmaceutical and agrochemical intermediate demand, chemical synthesis activity, grade mix, form, purity, end-user qualification requirements, direct-versus-indirect channel mix and country-level manufacturing intensity.
• Data Validation and Update Cycle: Findings are cross-checked against supplier product specifications, public industrial statistics and industry interviews. Updates account for changes in drug approvals, agrochemical registration activity, manufacturing output, hazardous-material logistics and high-purity qualification requirements.

• By Product:

  • Industrial Grade Butyryl Chloride
    • Bulk Chemical Grade
    • Intermediate Grade
  • High Purity Butyryl Chloride
    • Pharmaceutical Grade
    • Electronic Grade
  • Specialty Derivatives
    • Butyryl Based Intermediates
    • Custom Synthesis Grade

• By Application:

  • Pharmaceuticals
    • API Synthesis
    • Fine Chemical Synthesis
  • Agrochemicals
    • Herbicide Intermediates
    • Pesticide Intermediates
  • Polymers And Chemicals
    • Polymer Modification
    • Industrial Chemical Synthesis
  • Dyes And Pigments
    • Organic Dyes
    • Industrial Pigments

• By End Use:

  • Pharmaceutical Companies
  • Chemical Manufacturers
  • Agrochemical Companies
  • Specialty Chemical Producers
  • Research And Development Laboratories

• By Form:

  • Liquid
    • Bulk Liquid
    • Stabilized Liquid
  • Intermediate Solid Derivatives
    • Purified Solid Forms
    • Reaction Stabilized Forms

• By Purity Grade:

  • Industrial Grade
  • Technical Grade
  • Pharmaceutical Grade
  • High Purity Grade

• By Distribution Channel:

  • Direct Sales
  • Indirect Sales
    • Distributors
    • Online B2B Platforms